NICHOLS WILLIAM GARRETT (Chief Medical Officer) sold 1.8% of their position (937.00 shares) of CANDEL THERAPEUTICS, INC. on the open market
Open‑market sale worth $6.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/30/2025ACC: 0000950170-25-100320
Officer· Chief Medical Officer
Since Jan 2026
-937.00
Net shares
Net seller
$6.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
937.00 acquired · 1.87K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+937.00
Price / share
$1.29
Trade value
$1.21K
% of position
1.8%
7/28/2025
52.49K→53.43K
Common Stock
Direct
Shares
−937.00
Price / share
$6.98
Trade value
$6.54K
% of position
1.8%
7/28/2025
53.43K→52.49K
Total
Net shares
+0.00
Net value
-$5.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/28/2025 | M · Option Exercise | +937.00 | $1.29 | $1.21K | 1.8% | 52.49K | 53.43K |
| Common Stock Direct | 7/28/2025 | S · Sale | −937.00 | $6.98 | $6.54K | 1.8% | 53.43K | 52.49K |
| Total | +0.00 | -$5.33K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
937.00 shares
Shares
−937.00
Strike price
1.29
Held after
29.38K
Exercisable
—
7/28/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock937.00 shares | 7/28/2025 | M · Option Exercise | −937.00 | 1.29 | — | 29.38K |